Sanofi Fined $52.8 Million for Denigrating Plavix Copies

The pharmaceutical company Sanofi has launched the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based

With operations in more than 100 countries and more than 110,000 staff, global healthcare company Sanofi needed a way to streamline processes and transform its technology infrastructure into an efficient global network. To do this, Sanofi turned to ...

Analyst says GSK, Sanofi, India's Cipla will take hardest hit in move Share Tools India has started the countdown on new price controls for a vastly expanded list of drugs, a move that is expected to cut deeply into the profits of drugmakers for ...

Limited resources and lack of awareness make certain health problems low priority in developing countries Flickr/Sanofi Pasteur [SANTIAGO] Latin America and the Caribbean face a cancer crisis that "threatens to cause widespread suffering and ...

PR Newswire/Les Echos/ PRESS RELEASE Sanofi appoints David Loew, Senior Vice President, Commercial Operations, Europe Paris, France - May 23, 2013 - Sanofi (EURONEXT : SAN and NYSE : SNY) is pleased to announce today the appointment of David Loew, ...

Following its launch in November 2012, the 'My Diabetes Story' Community, an online network led by diabetics exclusively for diabetics in the Middle East, has rapidly grown as over 1000 members have registered. Led by 'My Diabetes Story' Ambassadors ...

India's health ministry is tying itself in knots over the ban of drugs that are banned in some countries, and, in some cases, for some population segments. In an action-taken report submitted on 26 April by the ministry in response to a study by a ...

The Korean branch of Sanofi Pasteur, a French vaccine manufacturer, said Wednesday it would provide free flu vaccines to 7,000 homeless people this year. The drug maker has signed a memorandum of understanding with the Korea Association of Welfare ...

Research and Markets (http://www.researchandmarkets.com/research/4zjcqb/aubagio_multiple) has announced the addition of the "Aubagio (Multiple Sclerosis) - Forecast and Market Analysis to 2022" report to their offering. PharmaPoint Drug Evaluation ...